| P50 | author | Stefan D. Anker | Q30310195 |
| | Stephan von Haehling | Q50639680 |
| P2093 | author name string | Jochen Springer | |
| | Masaaki Konishi | |
| | Junichi Ishida | |
| P2860 | cites work | Global trend in overweight and obesity and its association with cardiovascular disease incidence | Q27027564 |
| | Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee | Q29619180 |
| | Cachexia: a new definition | Q34013455 |
| | One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA. | Q34034275 |
| | Definition and classification of cancer cachexia: an international consensus | Q34162846 |
| | Cachexia as a major underestimated and unmet medical need: facts and numbers | Q34176827 |
| | Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial | Q34260028 |
| | Cachexia as a major public health problem: frequent, costly, and deadly | Q34335859 |
| | Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer | Q34549970 |
| | Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. | Q34591010 |
| | Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan | Q34700758 |
| | Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients | Q35605830 |
| | Request for regulatory guidance for cancer cachexia intervention trials. | Q36349332 |
| | Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease | Q37255730 |
| | Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies | Q37635897 |
| | Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia | Q38181647 |
| | Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. | Q38670653 |
| | Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014 | Q41787049 |
| | The relationship between obesity and mortality in patients with heart failure | Q43723158 |
| | Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors | Q43774896 |
| | Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer | Q43851502 |
| | Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan | Q44172285 |
| | Guidelines for treatment of acute heart failure (JCS 2011). | Q44415700 |
| | Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer | Q44457880 |
| | Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure | Q44743992 |
| | Treatment of cachexia with ghrelin in patients with COPD. | Q46703228 |
| | Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial | Q48051450 |
| | The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patients. | Q53066365 |
| | New criteria for 'obesity disease' in Japan. | Q53667063 |
| | Factors associated with malnutrition in patients with head and neck cancer | Q58084060 |
| | Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer | Q77801627 |
| | Increased plasma ghrelin level in lung cancer cachexia | Q78952969 |
| | Both High and Low Body Mass Indexes are Prognostic Risks in Japanese Patients With Chronic Heart Failure: Implications From the CHART Study | Q82340018 |
| | Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients | Q83730930 |
| | Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs | Q84461274 |
| | Clinical and inflammatory factors associated with body mass index in elderly patients with chronic obstructive pulmonary disease | Q84537992 |
| | Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts long-term mortality | Q84589644 |
| | Evidence-based practice guideline for the treatment of CKD | Q84978295 |
| | Impact of body mass index on mortality in heart failure patients | Q85832093 |
| | Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy | Q85894772 |
| | Family history, body mass index and survival in Japanese patients with stomach cancer: a prospective study | Q88008389 |
| P433 | issue | 5 | |
| P304 | page(s) | 515-519 | |
| P577 | publication date | 2016-04-12 | |
| P1433 | published in | Journal of Cachexia, Sarcopenia and Muscle | Q6294897 |
| P1476 | title | Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact | |
| P478 | volume | 7 | |